Antacids Market 2028 – Overview of Key Trends, COVID-19

Dallas, Texas, May 28, 2021 (GLOBE NEWSWIRE) – “Global Antacids Market Size by Dosage Form (Liquid, Tablet, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region ( North America), Europe, Asia-Pacific, Middle East & Africa, Latin America) Global Forecast 2018 to 2028 ”study provides a detailed view of historical, present and forecast market estimates.

Request for Sample Report:

The global antacids market is valued at USD 5.8 billion in 2019, with a CAGR of 3.8%. Increasing prevalence of gastroesophageal reflux disease (GERD), growing geriatric population across the world coupled with increasing cases of heartburn are major factors in the global antacids market.

The Adroit Market Research study on the Global Antacids Market offers a holistic view of the industry from 2020 to 2028 as a forecast period including factors such as market drivers, limitations, opportunities, challenges and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2019 and a projection of 2021 to 2028. The report covers the current status and potential characteristics of the market at global and country level. Moreover, the report also assesses the competition in the market through Porter’s analysis of five strengths and places leading players on the basis of their product line, regional presence, strategic initiatives and sales. global. The major players operating in the global antacids market have been studied in detail.

For more information on the analysis of this report, visit:

Antacids are drugs that neutralize stomach acid to relieve symptoms such as heartburn, sour stomach, acid indigestion, and stomach irritation, all of which are symptoms of gastroesophageal reflux disease (GERD). ), also known as acid reflux or dyspepsia. They contain alkalizing ingredients such as aluminum, calcium, magnesium or sodium bicarbonate, which serve as bases to neutralize stomach acid. The increasing prevalence of these gastrointestinal diseases around the world is a major driver of the global antacids market. In addition, the increase in the number of geriatric patients susceptible to gastric diseases should allow a strong expansion of the market in the coming years. However, antacids have been linked to allergic reactions in some individuals. Antacids containing magnesium can cause diarrhea, while antacids containing calcium and aluminum can cause constipation. Long-term use of antacids can lead to kidney stones and increase the risk of osteoporosis. These factors are expected to hamper the growth of the market during the forecast period.

The global antacids market has been segmented on the basis of dosage form, distribution channel, and region. On the basis of dosage form, the antacids market is segmented into liquid, tablets, and others. The tablet segment held the majority of the market share in 2019. On the basis of the distribution channel, the global antacids market is classified into retail pharmacy, hospital pharmacy, and online pharmacy. The over-the-counter availability of antacids has complemented the penetration of these drugs in convenience stores, retail pharmacies and online pharmacies.

Do you want to get the data? Buy here at:

Asia-Pacific has dominated the global antacids market and is expected to create immense growth opportunities in the future. The increase in the number of geriatric patients in emerging countries such as India and China who are prone to developing gastric diseases is expected to drive the market growth in the region. North America held a significant share of the global antacids market in 2019. The increasing prevalence of gastric distress as well as the presence of a large number of heartburn patients in the United States are factors. key factors likely to drive the market growth over the next few years. For example, according to the American College of Gastroenterology, an estimated 60 million people in the United States suffer from heartburn, which is expected to drive the demand for antacids in the country.

The major players operating in the global antacids market are Bayer AG, GlaxoSmithKline plc, Pfizer, Inc., Sanofi, Abbott, Reckitt Benckiser Group plc, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd. and Procter & Gamble among others.

Are you looking for a discount? If so, contact us at:

Main points from the table of contents:

  1. introduction
  2. Research methodology
  3. Market outlook
  4. Antacids Market by Dosage Form, 2018-2028 (USD Million)
  5. Antacids Market by Distribution Channel, 2018-2028 (USD Million)
  6. Antacids Market by Region 2018-2028 (USD Million)
  7. Competitive landscape
  8. Company Profiles
  9. appendix

Access the research repository for upcoming reports @

About Us:

Adroit Market Research is a global business analysis and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product / technology development institutions and industry associations that require expertise. understanding of market size, key trends, participants and the future. perspectives of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market information to help them create opportunities that increase their income. We follow a code – Explore, Learn and Transform. At the core, we are curious people who enjoy identifying and understanding industry patterns, creating in-depth study around our results, and producing roadmaps to making money.

Contact us:

Ryan johnson

Account Manager – World

3131 McKinney Avenue, 600 Street

Dallas, TX 75204

Email ID: [email protected]

Phone number: +1.210.667.2421

Connect with us: Facebook | Twitter | LinkedIn

About Terry Gongora

Check Also

Indiana Coronavirus Updates for September 18, 2022

Sunday’s latest updates on the coronavirus pandemic for September 18, 2022. INDIANAPOLIS — Here are …

Leave a Reply

Your email address will not be published.